AgeX Therapeutics AGE
$ 11.3
-10.17%
Quarterly report 2024-Q3
added 11-12-2024
Country |
- |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NYSE AMERICAN |
CEO |
Dr. Michael West |
Employees in the company |
17 |
Shares |
1.08 K |
Market Cap[1] |
$ 12.2 K |
EBITDA (LTM) |
$ -8.5 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.